Skip to Content
Merck
  • [Operational mechanism modification of bone mechanostat in an animal model of nutritional stress: effect of propranolol].

[Operational mechanism modification of bone mechanostat in an animal model of nutritional stress: effect of propranolol].

Revista de investigacion clinica; organo del Hospital de Enfermedades de la Nutricion (2013-06-12)
Patricia Mabel Pintos, Christian Esteban Lezón, Clarisa Bozzini, Silvia María Friedman, Patricia Mónica Boyer
ABSTRACT

Propranolol (P) treatment exerts a preventive effect against the detrimental consequences to bone status in mildly chronically food-restricted growing rats (NGR) by an increment in cortical bone and by improving its spatial distribution. To study the effect of beta-blocker on operational mechanism of bone mechanostat in an animal model of nutritional stress. Weanling male Wistar rats were randomly assigned to four groups: control (C), C + P (CP), NGR and NGR + P (NGRP). C and CP rats were fed freely with the standard diet. NGR and NGRP rats received, for 4 weeks, 80% of the amount of food consumed by C and CP respectively, the previous day, corrected by body weight. Propranolol (7 mg/kg/day) was injected ip 5 days per week, for four weeks in CP and NGRP rats. C and NGR received saline injections at an identical dosage regimen. Body weight and length were determined during the experimental period. Dietary intake was registered daily. Animals were sacrificed after 4 weeks of food restriction. Immediately, cuadriceps, femur and tibiae from each animal were dissected and weighed, and histomorphometric and mechanical studies were performed. Serum a-CTX, osteocalcin, intact PTH, calcium and phosphorous were determined. Body protein (% prot) was measured in all groups. Food restriction induced detrimental effects on body and femoral growth, load-bearing capacity (Wf), % prot and cuadriceps weight in NGR us. C (p < 0.01). beta-blocker did not modify anthropometric and bone morphometric parameters in NGRP and CP us. NGR and C, respectively (p > 0.05). However, Wf NGRP vs. NGR was significantly higher (p < 0.01). alpha-CTX was significantly higher in NGR vs. C (p < 0.01). No significant differences were observed in alpha-CTX levels between CP, NGRP and C (p > 0.05). Serum osteocalcin, intact PTH, calcium and phospho- rous showed no significant difference between groups (p > 0.05). These results suggest that modeling increase in bone mass and strength in NGRP rats could be due to an anticatabolic interaction of the beta-blocker propranolol on operational mechanism of bone mechanostat in an animal model of nutritional stress.

MATERIALS
Product Number
Brand
Product Description

Supelco
Propranolol hydrochloride, Pharmaceutical Secondary Standard; Certified Reference Material
Propranolol hydrochloride, European Pharmacopoeia (EP) Reference Standard
Sigma-Aldrich
(±)-Propranolol hydrochloride, ≥99% (TLC), powder
Supelco
Propranolol hydrochloride solution, 1.0 mg/mL in methanol (as free base), ampule of 1 mL, certified reference material, Cerilliant®